Intra Cellular Therapies | Kostnadene For Salg

Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 17.89M 3.27M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Halozyme Therapeutics USD 52.3M 2.52M 2023-12
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
RedHill Biopharma USD 806K 806K 2023-06
Supernus Pharmaceuticals USD 19.63M 26K 2023-12



Intra Cellular Therapies Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.